These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 9516849

  • 1. Analysis of candidate gene co-amplification with MYCN in neuroblastoma.
    George RE, Kenyon R, McGuckin AG, Kohl N, Kogner P, Christiansen H, Pearson AD, Lunec J.
    Eur J Cancer; 1997 Oct; 33(12):2037-42. PubMed ID: 9516849
    [Abstract] [Full Text] [Related]

  • 2. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
    George RE, Kenyon RM, McGuckin AG, Malcolm AJ, Pearson AD, Lunec J.
    Oncogene; 1996 Apr 04; 12(7):1583-7. PubMed ID: 8622876
    [Abstract] [Full Text] [Related]

  • 3. Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma.
    Kaneko S, Ohira M, Nakamura Y, Isogai E, Nakagawara A, Kaneko M.
    J Cancer Res Clin Oncol; 2007 Mar 04; 133(3):185-92. PubMed ID: 17028906
    [Abstract] [Full Text] [Related]

  • 4. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma.
    Squire JA, Thorner PS, Weitzman S, Maggi JD, Dirks P, Doyle J, Hale M, Godbout R.
    Oncogene; 1995 Apr 06; 10(7):1417-22. PubMed ID: 7731693
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype?
    Scott D, Elsden J, Pearson A, Lunec J.
    Cancer Lett; 2003 Jul 18; 197(1-2):81-6. PubMed ID: 12880964
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma.
    Kramer K, Cheung NK, Gerald WL, LaQuaglia M, Kushner BH, LeClerc JM, LeSauter L, Saragovi HU.
    Eur J Cancer; 1997 Oct 18; 33(12):2098-100. PubMed ID: 9516861
    [Abstract] [Full Text] [Related]

  • 19. Expression of two dead box genes (DDX1 and DDX6) is independent of that of MYCN in human neuroblastoma cell lines.
    Akiyama K, Akao Y, Yokoyama M, Nakagawa Y, Noguchi T, Yagi K, Nishi Y.
    Biochem Mol Biol Int; 1999 Apr 18; 47(4):563-8. PubMed ID: 10319407
    [Abstract] [Full Text] [Related]

  • 20. Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon.
    Frühwald MC, O'Dorisio MS, Rush LJ, Reiter JL, Smiraglia DJ, Wenger G, Costello JF, White PS, Krahe R, Brodeur GM, Plass C.
    J Med Genet; 2000 Jul 18; 37(7):501-9. PubMed ID: 10882752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.